News
To deal with rising costs, employers are leveraging high performance networks, variable copay plans and exclusive provider organization plans.
Osmol Therapeutics E.U. Patent Allowance for Novel Therapy Targeting Chemotherapy-induced Neuropathy
Osmol Therapeutics, a privately held clinical-stage biopharmaceutical company focused on developing preventative treatments ...
But experts say there are serious risks to taking too much of the drug—or taking it too long. Diphenhydramine, a common antihistamine found in over-the-counter allergy and sleeping medications ...
Lately, including earlier today, we have been focusing on patent affairs in Poland. Those are connected to and similar to EPO ...
Particular criticism, we have learned, is directed at the manipulation of data in the Office's databases and at legislative ...
Luspatercept led to durable red blood cell transfusion independence and early OS signals in ESA-naive, lower-risk MDS, per ...
Usman Nurmagomedov has a near-perfect MMA record of 19-0 (1 No Contest), with the only blemish on his resume being a failed drug test in 2023.
Former Bellator lightweight title challenger Alexander Shabliy has accepted a six-month suspension handed down by the United States Anti-Doping Agency after he tested positive for a banned substance ...
On Wednesday, the U.S. Anti-Doping Agency announced that Shabliy accepted a six-month suspension for failing a drug test caused by a sample collected March 19. Shabliy, 32, tested positive for ...
Professional Fighters League lightweight Alexandr Shabliy has accepted a six-month suspension for a failed drug test, USADA ...
The table below is a review of notable updates that occurred in May 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results